I have just received the following response from Dr Brian Ziegelaar in relation to Prof. Keith Harding:-
"Professor Harding is still involved, we have ongoing dialogue for developing programs to help commercialise VitroGro®ECM with the Welsh Wound Innovation Initiative. The aim of these programs is to work with Prof. Harding to expand the use of VitroGro®ECM in order to help patients suffering with Venous Leg Ulcers in the United Kingdom."
Regards................................
TIS Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held